Peptide Dosages

5-Amino 1MQ

Adamax

Adipotide

AOD 9604

ARA 290

B12 

BPC-157

Cagrilintide

Cagrilinitide (or “Cagri”) is a long-acting, lipidated, albumin-binding amylin agonist that targets both amylin and calcitonin receptors. It is used in the treatment of obesity, either on its own or in combination with GLP-1 receptor agonists. Amylin is co-secreted with insulin from pancreatic beta cells and regulates appetite, satiety, gastric emptying, and glucose control.

Combining Cagrilinitide with a GLP-1 like Semaglutide has a synergistic effect, amplifying weight loss beyond what either peptide achieves independently. Other benefits include improved circulation, reduced blood pressure, enhanced bone-building activity, and vasodilation.

  • 6–10% body weight loss at 26 weeks (Cagrilinitide alone)
  • 23–24.4% body weight loss at 68 weeks (combined with Semaglutide)
  • Synergistic effect: up to 8% more weight loss vs. Semaglutide alone
  • Injection site reaction (redness, swelling, itching, hives)
  • Nausea
  • Vomiting
  • Constipation
  • Fatigue
  • Headache
  • Diarrhea
  • Heartburn
  • Gallbladder stones (rare)

CAGRILINITIDE: 10MG

Mix with 2mL (200 units) of BAC water

8 week cycle followed by 4-8 week washout period

Subcutaneous Administration


  • Week 1: 4 units (200mcg)
  • Week 2: 8 units (400mcg)
  • Wee 3: 15 units (750mcg)
  • Week 4: 24 units (1.2mg)
  • Week 5: 34 units (1.7mg)
  • Week 6: 44 units (2.2mg)
  • Week 7-8: 54 units (2.7mg)

Important Notes

  • Always dose on the same day each week
  • Ensure adequate hydration throughout the cycle
  • Do not exceed 12 consecutive weeks of use
  • Anti-Cagri antibodies may form with extended use (46–73% of users)

Stacking Suggestions

  • Semaglutide, Tirzepatide, or Retatrutide – Boosts appetite suppression and fat loss via GLP-1 synergy- plateau breaker
  • Tesofensine – Enhances energy expenditure and thermogenesis
  • L-Carnitine – Supports fat metabolism and energy conversion
  • AOD-9604 – Encourages lipolysis and body fat reduction without affecting blood sugar

Are you satisfied with this article? Usefulness of the article: 1 / 0

CagriSema

CagriSema (Cagrilinitide + Semaglutide)

CagriSema is a powerful combination of Cagrilinitide, a long-acting amylin analogue, and Semaglutide, a GLP-1 receptor agonist. Together, they regulate satiety, control blood sugar, and significantly reduce body weight — achieving results comparable to Tirzepatide, but through a synergistic dual mechanism.


How It Works

  • Cagrilinitide: A stabilized amylin analogue that resists enzymatic breakdown, prolonging its effects.
    • Induces satiety and reduces food intake
    • Suppresses glucagon (which raises blood sugar)
    • Slows gastric emptying, enhancing fullness
    • Promotes vasodilation, improving circulation
    • Supports bone health by reducing osteoclast activity and increasing osteoblast activity
  • Semaglutide: A GLP-1 receptor agonist that:
    • Suppresses appetite via hypothalamic signaling
    • Reduces glucagon secretion
    • Delays gastric emptying
    • Aids glucose regulation

Research-Based Benefits

  • Average 23–24.4% total body weight loss (vs. 15–17% with Semaglutide alone)
  • Comparable to weight loss achieved by Tirzepatide
  • Greater impact than using either compound individually
  • May support bone density, cardiovascular health, and glucose control

Dosing Guidelines

CagriSema: 5MG/5MG
Mix with 1.5mL (150 units) of BAC water
Subcutaneous Administration — dose weekly, on the same day each week

⚠️ Even if transferring from Semaglutide or another GLP-1, start at the lowest dose due to the potent effects of Cagrilinitide.

Week-by-Week Titration Protocol

  • Week 1–4: 5 units = 0.25mg
  • Week 5–8: 10 units = 0.5mg
  • Week 9–12: 15 units = 0.75mg
  • Week 13–16: 20 units = 1mg
  • Increase weekly as tolerated in 5-unit increments (0.25mg) until reaching:
    • 50 units = 2.5mg (maximum target dose)

Side Effects

Most are temporary and similar to other GLP-1 medications:

  • Nausea
  • Vomiting
  • Constipation or diarrhea
  • Headache
  • Abdominal discomfort
  • Injection site irritation

Contraindications

Do not use CagriSema if:

  • You have a personal or family history of Medullary Thyroid Carcinoma (MTC) or MEN2
  • You are allergic or hypersensitive to any of its components
  • You have a history of pancreatitis
  • You are pregnant or breastfeeding
  • You are currently using another GLP-1 drug (including microdoses)

Use with caution if:

  • You have renal dysfunction
  • You have cardiovascular instability
  • You have gastroparesis or other GI motility disorders

Storage

  • Store refrigerated
  • Do not freeze
  • Shelf life: Up to 12 months when properly stored

Stacking Suggestions

  • Tirzepatide (not to be used simultaneously) – An alternative to CagriSema with similar outcomes if CagriSema causes intolerance
  • Glutathione – Supports liver detox, blood sugar balance, and reduces oxidative stress
  • Vitamin B12 or MIC+C – Enhances energy, combats fatigue, and supports fat metabolism (especially important during calorie restriction)
  • Tesofensine – May amplify appetite suppression and support dopamine-based reward pathway modulation
  • GH Secretagogues (CJC-1295 + Ipamorelin) – Preserves muscle mass and supports metabolic health during fat loss
  • Thymosin Alpha-1 – Supports immune balance in individuals with metabolic or inflammatory conditions

Are you satisfied with this article? Usefulness of the article: 0 / 0

CJC1295 No DAC

CJC-1295 No DAC

CJC-1295 No DAC (No Drug Affinity Complex) is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to naturally stimulate the pituitary gland’s production of growth hormone (GH). It does this by mimicking GHRH activity and triggering powerful GH pulses—without remaining in circulation for extended periods like the DAC version. This shorter half-life closely mimics the body’s natural growth hormone rhythm, resulting in a more efficient and biologically aligned peptide therapy.

CJC No DAC has been shown to increase GH levels by up to 200–1000%, making it a powerful alternative to exogenous hGH, but without the drawbacks of suppression or long-term adaptation. It’s favored for fat loss, muscle recovery, anti-aging, and regenerative benefits.


Key Benefits

  • Stimulates lean muscle growth and recovery
  • Reduces adipose (fat) tissue
  • Increases bone density and skeletal strength
  • Promotes collagen synthesis (skin, joints, connective tissue)
  • Improves sleep cycles and circadian rhythm
  • Enhances energy levels and vitality
  • Strengthens the immune system
  • Accelerates connective tissue repair (tendons, ligaments)

Mechanism of Action

CJC-1295 No DAC acts on:

  • Growth Hormone Pathways: Triggers GH pulses from the pituitary gland
  • IGF-1 & LR3IGF-1: Elevates downstream markers responsible for muscle hypertrophy and regeneration
  • Albumin Binding & Circulation: Designed for rapid absorption and release (30 min half-life), avoiding desensitization

This short-duration activity prevents receptor downregulation and mimics how GH is naturally secreted in healthy individuals, especially during deep sleep and fasting.


Regenerative & Systemic Benefits

  • Boosts B and T-cell count in aging and immunocompromised individuals
  • Increases antibody production, improving immune resilience
  • Supports stem cell regeneration after organ or tissue damage
  • Stimulates pancreatic cell proliferation
  • May help repair cardiac tissue after heart attacks
  • Enhances fertility and libido, especially in older adults
  • Reduces triglycerides and supports cardiovascular health through improved body composition
  • Shown to support cognition after neurological injury

CJC-1295 No DAC vs DAC Version

The primary difference between CJC No DAC and CJC DAC is the duration of action:

  • CJC DAC: 6–8 day half-life, constant systemic exposure, may lead to desensitization over time
  • CJC No DAC: 30-minute half-life, pulsed GH release, prevents adaptation, more closely mirrors natural GH production

CJC No DAC is preferred for longer-term use and bioidentical GH optimization.


Stacking with Ipamorelin

CJC-1295 No DAC is frequently stacked with Ipamorelin, a selective GH secretagogue that triggers additional GH pulses through a different pathway. When used together, the combo dramatically amplifies growth hormone output—leading to better muscle repair, fat loss, and recovery.

  • Both are administered simultaneously, often twice or three times per day for optimal synergy
  • This stack is safer and more effective than other GHRP combinations

Possible Side Effects

Common:

  • Redness or irritation at injection site
  • Temporary water retention
  • Increased appetite
  • Mild fatigue
  • Flushing or warmth
  • Light-headedness or dizziness
  • Headache or nausea
  • Digestive upset (bloating, diarrhea)
  • Tingling sensations
  • Mild hyperactivity or jitteriness

Rare:

  • Temporary increase in blood pressure or pulse
  • Hives or allergic skin reactions

Side Effect Management

  • Start low, go slow: Gradually increase dosing over time
  • Hydrate aggressively to manage water retention
  • Use magnesium to counter water retention naturally
  • For persistent side effects, consult a physician

Contraindications

Do NOT use CJC-1295 No DAC (alone or with Ipamorelin) if:

  • You are pregnant or breastfeeding
  • You are currently using other GH secretagogues or growth hormone supplements
  • You have active cancer, untreated cardiovascular conditions, or hormonal disorders
  • You are hypersensitive to peptide-based medications

Dosing Protocol

CJC-1295 NO DAC: 10MG – RECONSTITUTION AND DOSING

Subcutaneous Administration

.3mL/cc (30-unit) or .5mL/cc (50-unit) syringes recommended


Low-Dose Protocol (General Benefits / Anti-Aging / Women)

  • Weeks 1–4 (or 1–6): 3 units (100mcg), once daily
  • Weeks 5–12: 5 units (150mcg), once daily

2x/Day Protocol (Muscle Tone, Mild Recovery)

  • Week 1: 3 units (100 mcg), 2x/day
  • Weeks 2–4 (or 2–6): 5 units (200 mcg), 2x/day
  • Weeks 5–8 (or 7–12): 8 units (300 mcg), 2x/day

3x/Day Protocol (Athletes / Bodybuilders / Max Recovery)

  • Days 1–3: 4 units (150 mcg), 3x/day
  • Days 4–7: 5 units (200 mcg), 3x/day
  • Weeks 2–3: 8 units (300 mcg), 3x/day
  • Weeks 4–6: 10 units (400 mcg), 3x/day
  • Weeks 7–12: 13 units (500 mcg), 3x/day

STACKING SUGGESTIONS

To maximize results and drive more conversions:

  • Ipamorelin – Boosts GH secretion through synergistic action
  • TB-500 / BPC-157 – For injury recovery, tissue regeneration, and joint health
  • AOD-9604 – Supports fat metabolism without muscle loss
  • GHK-Cu – Skin and tissue repair, anti-aging benefits
  • Glutathione – Cellular detox, immune support

Are you satisfied with this article? Usefulness of the article: 0 / 0

CJC-1295 No DAC / IPA Blend

Crystagen

Dihexa (Oral)

Dihexa/Tesofensine/Methylene Blue (Oral) (Oral) . . .

DSIP

Epithalon/Epitalon

FOX04 DRI

GHK-Cu

GHRP-2

GHRP 6

GLOW

Glutathione

HCG

IGF1-LR3

Ipamorelin

Kisspeptin

Klow

KPV

L-Carnitine

LL-37

Mazdutide

Melanotan-2

Methylene Blue (Oral)

MitoPrime Blend

MOTS-c

Nad+

Orforglipron (Oral)

Oxytocin

Pancragen

Pinealon

Prostamax

PT-141

Selank

Semax

Sermorelin

SNAP-8 (Acetyl Octapeptide-3)

SS-31

Survodutide

TB-500

Tesamorelin

Thymosin Alpha-1

Vilon

Semaglutide

Tesofensine

Tirzepatide

Retatrutide